《2017年世界毒品问题报告》：Presentation(PPT版本).pptVIP

* * * * * * * * * * * * * * * * * * * * * * Regulations of recreational cannabis use Jurisdictions in the United States allowing recreational use, medical use of cannabis and with no access to cannabis, May 2017 Regulations of recreational cannabis use, US Cannabis use patterns, risk perception, availability, medical cannabis Cannabis use initiation in the past year Cannabis use disorders in daily or near-daily users Expanding market: Amphetamine-type stimulants (ATS) Total ATS seizures: highest ever Amphetamine and methamphetamine constitute considerable share of burden of disease, rank second only after opioids Users of amphetamines increased, reaching 37 million globally Methamphetamine seizures up, East and South-East Asia overtaking North America “Ecstasy” seizures stable but greater variety of products on the market ATS seized worldwide Methamphetamine: interregional trafficking flows Expanding market in East/South-East Asia, Oceania, concerns about growing use in North America, South-West Asia and parts of Europe. Rising treatment demand in some regions. Amphetamine: trafficking spreading beyond traditional regions Amphetamine seizures up in Middle East and Central America In the Near and Middle East, sold as “captagon” tablet Trafficking of amphetamine affecting more regions as transit or origin Central America emerging as origin of amphetamine Amphetamine seized worldwide Expanding market: New psychoactive substances Between 2009-2016, 739 different NPS reported In 2015 alone, almost 500 NPS were on the market worldwide Core group of about 80 persistent NPS Innovation continues but at slower pace NPS with stimulant properties expand in number Recent emergence of NPS mimicking medicines (fentanyl analogues, benzodiazepine derivatives) with high potential to cause harm No. of different NPS reported each year UNODC, early warning advisory on new psychoactive substances. NPS use Overall size of market for NPS still relatively small Many NPS user